Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Complementary Options for Symptom Management In Cancer (COSMIC): Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics

NCT06418204 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT06418204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06418204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Complementary Options for Symptom Management In Cancer (COSMIC): Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics
Lead sponsor
Wake Forest University Health Sciences
Phase
Observational
Overall status
Recruiting
Start date
January 30, 2025
Completion date
August 1, 2028
Enrollment
2,000 (estimated)
Sites
486

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma, colorectal carcinoma, lung non-small cell carcinoma, melanoma, non-hodgkin lymphoma